Jazz Pharmaceuticals PLC (JAZZ)
124.41
-2.26
(-1.78%)
USD |
NASDAQ |
Nov 25, 14:57
Jazz Pharmaceuticals Profit Margin (Quarterly): 20.38% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 20.38% |
| June 30, 2024 | 16.46% |
| March 31, 2024 | -1.62% |
| December 31, 2023 | 9.30% |
| September 30, 2023 | 15.10% |
| June 30, 2023 | 10.91% |
| March 31, 2023 | 7.78% |
| December 31, 2022 | -24.76% |
| September 30, 2022 | -2.09% |
| June 30, 2022 | 3.72% |
| March 31, 2022 | 0.20% |
| December 31, 2021 | -3.94% |
| September 30, 2021 | -6.30% |
| June 30, 2021 | -48.33% |
| March 31, 2021 | 20.05% |
| December 31, 2020 | 20.05% |
| September 30, 2020 | 24.67% |
| June 30, 2020 | 20.41% |
| March 31, 2020 | -29.52% |
| December 31, 2019 | 12.72% |
| September 30, 2019 | 19.02% |
| June 30, 2019 | 49.03% |
| March 31, 2019 | 16.77% |
| December 31, 2018 | 33.47% |
| September 30, 2018 | 31.81% |
| Date | Value |
|---|---|
| June 30, 2018 | 18.45% |
| March 31, 2018 | 10.34% |
| December 31, 2017 | 53.21% |
| September 30, 2017 | 15.42% |
| June 30, 2017 | 26.78% |
| March 31, 2017 | 23.00% |
| December 31, 2016 | 29.42% |
| September 30, 2016 | 24.01% |
| June 30, 2016 | 30.04% |
| March 31, 2016 | 22.56% |
| December 31, 2015 | 24.28% |
| September 30, 2015 | 25.80% |
| June 30, 2015 | 26.40% |
| March 31, 2015 | 22.86% |
| December 31, 2014 | 24.87% |
| September 30, 2014 | 8.40% |
| June 30, 2014 | 14.99% |
| March 31, 2014 | -37.52% |
| December 31, 2013 | 23.45% |
| September 30, 2013 | 32.48% |
| June 30, 2013 | 20.26% |
| March 31, 2013 | 22.13% |
| December 31, 2012 | |
| September 30, 2012 | 18.92% |
| June 30, 2012 | 21.85% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-48.33%
Minimum
Jun 2021
24.67%
Maximum
Sep 2020
3.26%
Average
8.54%
Median
Profit Margin (Quarterly) Benchmarks
| Avadel Pharmaceuticals PLC | -5.25% |
| Alkermes PLC | 24.43% |
| Medtronic PLC | 15.11% |
| Perrigo Co PLC | -1.93% |
| Iterum Therapeutics PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.28% |
| Return on Assets | 4.02% |
| Return on Invested Capital | 4.84% |
| Gross Profit Margin (Quarterly) | 89.42% |
| Operating Margin (Quarterly) | 24.67% |
| Return on Net Operating Assets | 5.05% |